April 17 Day 3 - 10 Co-conferences & Plenary

Vaccine Safety Case Studies

Precision Cancer Treatment

Engineered Cancer Immunotherapy: T cells to Bispecifics, and beyond

Respiratory Infections Strategy & Control

Eliminating Global Infectious Diseases

Manufacturing Platforms

Alternatives to Antibiotics

Emerging and Re-emerging Diseases
09:10

What the gates MRI are doing: TB, malaria, enteric

Bioprocessing & Manufacturing Conference
09:40

Manufacturing technology showcase

Practical solutions enabling rapid and sustainable productionSenior representation, Paragon
Immune Profiling Conference

Biomarker Strategies & Patient Centricity

Bioprocessing & Manufacturing Conference
10:25

Manufacturing technology showcase

Affinity chromatography for vaccines purification
10:40

Networking Coffee Break

Emerging & Re-Emerging Diseases

Bioprocessing & Manufacturing Conference
11:30

Incorporating AI and big data into more effective vaccine manufacturing

Vaccine Partnerships Conference
11:30

How to expand vaccine development of neglected diseases to a truly international level

Representatives from: Europe, Africa, Mexico, Saudi, South America- Challenges and disease targets of each market- Funding opportunities - Perspective partnerships
Mashal Almutairi, Assistant Professor, Pharmaceutical Biotechnology, King Saud university and Baylor College of Medicine
12:30

Networking Lunch & Poster Session

DAY 3 AFTERNOON PLENARY OF CONGRESS: RENAISSANCE BALLROOM

Paul Offit
13:40

New lessons from old controversies

  • What have we learnt from previous vaccines failures to drive new vaccines forward?
  • Why is there is low uptake on currently available vaccines? E.g. HPV & influenza
  • Examples and case studies from: Lyme & Rota – what does this mean for future vaccine innovation and R&D?
Dr Saad Omer
14:55

A framework for a comprehensive maternal immunization platform

  • Evidence for current immunization recommendations
  • Maternal vaccines in development
  • The need for evidence-based interventions at the practice, provider, and patient levels to ensure higher vaccination levels
Dr Timothy Cooke
16:00

Chair Closing Remarks and End of Congress

last published: 18/Mar/19 16:25 GMT

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington

 

To Sponsor Or Exhibit

Marc Rhys-Evans
marc.rhys-evans@terrapinn.com
+44 20 7827 5945

 

 

 

To Register

Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210

 

 

 

Press Relations

Karina Kusova
karina.kusova@terrapinn.com
+44 20 7092 1071